Evidence map›Paper›PMID 37305956›Full record

ArticleChembiochem : a European journal of chemical biology2023

Interrogation of an Enzyme Library Reveals the Catalytic Plasticity of Naturally Evolved [4+2] Cyclases.

Katja Zorn, Catherine R Back, Rob Barringer, Veronika Chadimová, Monserrat Manzo-Ruiz, Sbusisiwe Z Mbatha, Juan-Carlos Mobarec, Sam E Williams, Marc W van der Kamp, Paul R Race and 2 more

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Next-Generation Manufacturing: The Evolving Role of Biocatalysis in AstraZeneca.Chembiochem : a European journal of chemical biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Katja ZornCompound Synthesis and Management, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 431 83, Mölndal, Sweden.ORCID 0000-0001-5529-6484
Catherine R BackSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.ORCID 0000-0002-9835-9171
Rob BarringerSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.ORCID 0000-0002-0948-3761
Veronika ChadimováCompound Synthesis and Management, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 431 83, Mölndal, Sweden.ORCID 0000-0001-9707-5364
Monserrat Manzo-RuizSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.ORCID 0000-0003-2049-1487
Sbusisiwe Z MbathaSchool of Chemistry, University of Bristol, Bristol, BS8 1TS, UK.ORCID 0000-0002-4097-1034
Juan-Carlos MobarecMechanistic and Structural Biology, Biopharmaceuticals R&D, AstraZeneca, Cambridge, CB21 6GH, UK.ORCID 0000-0001-9482-4294
Sam E WilliamsSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.ORCID 0000-0002-6949-426X
Marc W van der KampSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.ORCID 0000-0002-8060-3359
Paul R RaceSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.ORCID 0000-0003-0184-5630
Christine L WillisSchool of Chemistry, University of Bristol, Bristol, BS8 1TS, UK.ORCID 0000-0002-3919-3642
Martin A HayesCompound Synthesis and Management, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 431 83, Mölndal, Sweden.ORCID 0000-0002-2640-8464

Funding

Medical Research Council MR/N0137941/1
6 · The paper itself

Abstract

Stereoselective carbon-carbon bond forming reactions are quintessential transformations in organic synthesis. One example is the Diels-Alder reaction, a [4+2] cycloaddition between a conjugated diene and a dienophile to form cyclohexenes. The development of biocatalysts for this reaction is paramount for unlocking sustainable routes to a plethora of important molecules. To obtain a comprehensive understanding of naturally evolved [4+2] cyclases, and to identify hitherto uncharacterised biocatalysts for this reaction, we constructed a library comprising forty-five enzymes with reported or predicted [4+2] cycloaddition activity. Thirty-one library members were successfully produced in recombinant form. In vitro assays employing a synthetic substrate incorporating a diene and a dienophile revealed broad-ranging cycloaddition activity amongst these polypeptides. The hypothetical protein Cyc15 was found to catalyse an intramolecular cycloaddition to generate a novel spirotetronate. The crystal structure of this enzyme, along with docking studies, establishes the basis for stereoselectivity in Cyc15, as compared to other spirotetronate cyclases.

Indexed as

CarbonProteinsCatalysisChemistry Techniques, SyntheticCycloaddition ReactionCarbonProteinsbiosynthetic gene clustercyclasesenzyme screeningintra-molecular Diels-Alder reactionpolyketides

Identifiers

PMID37305956
PMCPMC10946715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.